$RGBP While aplastic anemia impacts a small percentage of the population, it is an extremely lethal disease. In fact, patients with aplastic anemia typically die within one year of diagnosis. Immunosuppressive therapy has shown some positive impact on the disease but researchers are very cautious as to its efficacy in treating aplastic anemia. See R. Storb for detailed discussion (http://www.ncbi.nlm.nih.gov/pubmed/9423394)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.